Johnson and Johnson

Athlone stem student receives scholarship as part of Johnson & Johnson Award Programme The Westmeath Independent09:34County Galway Pharma Rep. of Ireland
We have made strategic choices for Indian market to grow, scale and meet unmet needs of consumers: Manish Anandani, MD, … The Financial Express14:10India Pharma
Pbm contracting and administration: What are the rules of the road for self-insured employees? JD Supra18:08Pharma
Derry woman among hundreds who may sue Johnson & Johnson over talc cancer claims Belfast Live17:58Pharma
Latest News

In the last 8 hours
J&J Shampoo Contamination Suit Sent Down The Drain Law36022:58 12-Dec-24
Johnson & Johnson to Participate in the 43rd Annual J.P. Morgan Healthcare Conference Johnson & Johnson (Press Release)21:31 12-Dec-24
Yesterday
Eight Limerick students honoured with Johnson and Johnson STEM awards Limerick Post17:07 12-Dec-24
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients Johnson & Johnson (Press Release)13:33 12-Dec-24
Johnson & Johnson is another big media win for WPP More About Advertising09:39 12-Dec-24
In the last 7 days
Using the Inflation Reduction Act to Rein in Patenting & Evergreening Abuses Public Citizen15:44 11-Dec-24
Elon Musk's Net Worth Surpasses Market Cap Of US Giants Like BofA, Johnson & Johnson, Salesforce, Chevron, Coca-Cola… Benzinga13:18 11-Dec-24
ASH 2024: J&J’s Tecvayli shows promise in transplant-eligible NDMM patient Pharmaceutical Technology10:27 11-Dec-24
Beasley Allen Told To Give Update On J&J Discovery Law36023:48 10-Dec-24
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex Benzinga18:24 10-Dec-24
Johnson & Johnson Just Paid Investors: Here's How Much They Received 24/7 Wall St.15:16 10-Dec-24
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results Johnson & Johnson (Press Release)13:05 10-Dec-24
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension… GlobeNewswire (Press Release)12:32 10-Dec-24
J&J presents positive phase 3 results for Darzalex Faspro in smouldering multiple myeloma PMLiVE12:22 10-Dec-24
Athlone STEM student receives scholarship as part of Johnson & Johnson Award Programme The Westmeath Independent09:34 10-Dec-24
CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) demonstrated significantly higher rates of minimal residual disease… GlobeNewswire (Press Release)08:07 10-Dec-24
CARVYKTI® (ciltacabtagene autoleucel) demonstrated significantly higher rates of minimal… PR Newswire (Press Release)00:39 10-Dec-24
Johnson & Johnson follows MSD to climb aboard Mestag’s RAFT Business Weekly16:24 9-Dec-24
Mestag Therapeutics Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform GlobeNewswire (Press Release)13:08 9-Dec-24
Warm autoimmune hemolytic anemia (wAIHA) research presented by Johnson & Johnson highlights profound disease burden and … Johnson & Johnson (Press Release)13:02 9-Dec-24
TECVAYLI® (teclistamab-cqyv) demonstrates potential as frontline combination therapy for… PR Newswire (Press Release)17:39 8-Dec-24
TECVAYLI®▼ (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed… GlobeNewswire (Press Release)17:38 8-Dec-24
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) shows 51 percent reduction in risk of… PR Newswire (Press Release)16:48 8-Dec-24
DARZALEX® (daratumumab) subcutaneous formulation shows 51 percent reduction in risk of progression to active multiple… GlobeNewswire (Press Release)16:26 8-Dec-24
Health Ministry Reconstitutes Panel To Compensate Patients Affected By J&J’s Faulty Hip Implants News18.com04:36 7-Dec-24
J&J Seeks New Talc Trial As Developer Seeks $30M More Law36000:48 7-Dec-24
Johnson & Johnson Is A Better Dividend Stock Than Amgen In Our View Seeking Alpha18:50 6-Dec-24
Is Johnson & Johnson Stock Underperforming the Nasdaq? Barchart12:02 6-Dec-24
Central expert panel to look into J&J implant compensations Hindustan Times00:56 6-Dec-24
In the last month
Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce Barchart22:58 5-Dec-24
Noteworthy Thursday Option Activity: CCK, JNJ, PII Nasdaq20:51 5-Dec-24
Johnson & Johnson MedTech Joins Experts to Define and Classify Surgical Site Outcomes Johnson & Johnson (Press Release)13:37 5-Dec-24
Galway STEM students receive scholarships as part of Johnson & Johnson’s WiSTEM2D Award Programme Galway Advertiser11:11 5-Dec-24
Medical Tapes Industry Report 2024, with Profiles of Leading Companies, including 3M, Johnson & Johnson, Smith &… GlobeNewswire (Press Release)18:53 4-Dec-24
J&J's Neosporin Forever Discolored Man's Groin, Suit Says Law36001:21 4-Dec-24
PBM Contracting and Administration: What Are the Rules of the Road for Self-Insured Employees? JD Supra18:08 3-Dec-24
We have made strategic choices for Indian market to grow, scale and meet unmet needs of consumers: Manish Anandani, MD, … The Financial Express14:10 3-Dec-24
Sarcoma Drugs Strategic Industry Research Report 2023-2024 & 2030, Competitive Profiles of 42 Players Including Amgen,… GlobeNewswire (Press Release)13:54 3-Dec-24
J&J’s sBLAs seek FDA approval of TREMFYA for paediatric conditions Pharmaceutical Technology11:18 3-Dec-24
J&J Lawsuits Seize on Uncertainty Over Meaning of ‘Plant-Based’ Bloomberg Law10:01 3-Dec-24
J&J Talc Cases to Remain on Hold Until Mid-March, Judge Rules Bloomberg Law20:58 2-Dec-24
Johnson & Johnson Files SBLAs In Pediatric Indications For Tremfya - Quick Facts RTT News13:37 2-Dec-24
Johnson & Johnson seeks U.S. FDA approval for first pediatric indications for TREMFYA® (guselkumab) Johnson & Johnson (Press Release)13:04 2-Dec-24
MENTOR™ MemoryGel™ Enhance Breast Implant Receives FDA Approval for Largest Size Breast Implants for Reconstruction Johnson & Johnson (Press Release)13:04 2-Dec-24
U.S. FDA Approves Biocon Biologics' YESINTEK™, Bmab 1200 Biosimilar to J&J's Stelara®… PR Newswire (Press Release)12:02 2-Dec-24
Money for Nothing? In an About Face, This Time the Third Circuit Said “Yes” Drug & Device Law10:04 2-Dec-24
Expansion of Johnson & Johnson on the Leiden Bio Science Park Leiden University09:51 2-Dec-24
Unlocking the Innovation Potential in Singapore’s Life Sciences Ecosystem BioSpectrum Asia19:18 1-Dec-24
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later The Motley Fool10:57 1-Dec-24
How To Build A $25,000 Dividend Portfolio, Johnson & Johnson As Your Core Holding Seeking Alpha20:00 28-Nov-24
3 Blue-Chip Stocks to Anchor Your Portfolio Entrepreneur Magazine12:37 28-Nov-24
Mallow stem student receives scholarship The Corkman12:20 28-Nov-24
J&J Sues HRSA Over Agency’s Challenge of its Rebate Model JD Supra07:22 28-Nov-24
Johnson & Johnson exec signs on for Algorae AI drug development The Sydney Morning Herald04:51 28-Nov-24
Baby Oral Care Products Market Global Forecasts and Company Analysis 2024-2032, Featuring Church & Dwight,… GlobeNewswire (Press Release)15:49 27-Nov-24
Johnson & Johnson announce recipients of Women in STEM2D Undergraduate Awards Business Plus Online14:07 27-Nov-24
Johnson & Johnson a Top 25 Dividend Giant With 3.21% Yield (JNJ) Nasdaq13:11 27-Nov-24
In 2024, the US and Europe led in pharma value creation while GLP-1s disrupted the landscape Drug Discovery & Development07:40 27-Nov-24
Beasley Allen Escapes Sanctions For J&J Deposition No Show Law36001:04 27-Nov-24
Derry woman among hundreds who may sue Johnson & Johnson over talc cancer claims Belfast Live17:58 26-Nov-24
Sanofi joins J&J, Eli Lilly in proposing 340B rebate model Healthcare Dive16:01 26-Nov-24
This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since… Johnson & Johnson (Press Release)15:13 26-Nov-24
2 Very Healthy Dividend Stocks to Hold for Decades of Income The Motley Fool11:25 26-Nov-24
Notable Monday Option Activity: MCD, ALB, JNJ Nasdaq19:58 25-Nov-24
After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists Johnson & Johnson (Press Release)16:10 25-Nov-24
J&J and Protagonist share promising phase 3 results for icotrokinra in plaque psoriasis PMLiVE12:32 25-Nov-24
Johnson & Johnson: Thousands plan legal action over alleged talc and cancer link Bucks Free Press15:43 24-Nov-24
'Why I blame Johnson and Johnson baby talc for cancer that robbed me of my voice' The Mirror12:45 23-Nov-24
Sanofi Offers New Payment Model for Drug Discount Program Bloomberg Law23:40 22-Nov-24
Read This Before Considering Johnson & Johnson (NYSE:JNJ) For Its Upcoming US$1.24 Dividend Simply Wall St22:50 22-Nov-24
Emergent's Vaccine Production Failure: Contamination Scandal, Investor Backlash, and $40M Settlement Benzinga20:40 22-Nov-24
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis Pharmaceutical Technology17:40 22-Nov-24
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings Nasdaq16:53 22-Nov-24
Health Canada issues NOC to J&J’s CARVYKTI for multiple myeloma Pharmaceutical Technology16:18 22-Nov-24
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals Forbes14:44 22-Nov-24
Johnson & Johnson Submits Sbla Seeking Approval Of Tremfya In Ulcerative Colitis RTT News13:52 22-Nov-24
Antihistamine Drugs Industry Report 2025-2030: A $381 Million Opportunity - Johnson & Johnson, Sanofi, Pfizer, and… GlobeNewswire (Press Release)13:41 22-Nov-24
Johnson & Johnson seeks U.S. FDA approval for subcutaneous induction regimen of TREMFYA®… PR Newswire (Press Release)13:01 22-Nov-24
UK claimants propose legal action against Johnson & Johnson over talc cancer claims British Medical Journal11:51 22-Nov-24
KP Law Leads Fight for Justice and Compensation in UK Johnson & Johnson Talc Cancer Cases Lawyer Monthly16:58 21-Nov-24
Irish woman battling cancer among thousands suing Johnson & Johnson over ‘baby powder link’ Sunday World15:23 21-Nov-24
'My wife died from ovarian cancer - talcum powder was to blame' Essex Live12:14 21-Nov-24
Derry woman joins lawsuit over talc cancer claims BBC10:50 21-Nov-24
Women plan to sue over talcum powder cancer claim Stoke-On-Trent Live10:28 21-Nov-24
Enclony partners with Johnson & Johnson on drug sample inspection project Korea Biomedical Review09:03 21-Nov-24
NI woman battling cancer among thousands suing over ‘baby powder link’ Belfast Telegraph07:45 21-Nov-24
Beasley Allen Rips J&J Sanctions Bid For Atty Depo No-Show Law36021:32 20-Nov-24
Johnson & Johnson now risks UK lawsuit over talc cancer claims News2417:26 20-Nov-24
Johnson & Johnson, Merck lay off workers in China as local headwinds take a toll FiercePharma16:39 20-Nov-24
Johnson & Johnson risks UK lawsuit over talc cancer claim YEN16:27 20-Nov-24
Unpacking Johnson & Johnson’s Lawsuit Over 340B Rebate Model JD Supra16:12 20-Nov-24
Derbyshire woman joins planned UK legal action over talc cancer claims Derbyshire Times14:01 20-Nov-24
Devastated dad who lost wife to ovarian cancer could sue amid talc cancer claims Gazette News13:45 20-Nov-24
Thousands of women plan legal action over alleged links between talc and cancer Belfast Telegraph13:26 20-Nov-24
Johnson & Johnson Starkly Portray Reality of Severe Depression with Powerful Film Little Black Book11:12 20-Nov-24
J&J, Merck Cut Jobs in China as Local Competition Takes Toll BNN Bloomberg08:35 20-Nov-24
'We thought talcum powder was safe' BBC06:26 20-Nov-24
J&J Wants Beasley Allen Atty Sanctioned For Depo No-Show Law36021:58 19-Nov-24
Johnson & Johnson: Policy Uncertainty Elevated, But Shares Remain Inexpensive Seeking Alpha18:14 19-Nov-24
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the… PR Newswire (Press Release)14:06 19-Nov-24
Biolojic Design Joins Johnson & Johnson Innovation - JLABS GlobeNewswire (Press Release)13:04 19-Nov-24
Johnson & Johnson reports topline outcomes from trial of icotrokinra for psoriasis Clinical Trials Arena11:01 19-Nov-24
J&J plots filings after psoriasis drug clears phase 3 test pharmaphorum10:50 19-Nov-24
J&J Posts $1.17B Bond For Del. Merger Milestone Appeal Law36002:49 19-Nov-24
Johnson & Johnson appoints CIO to lead business technology strategy CIO Dive21:55 18-Nov-24
Icotrokinra delivered an industry-leading combination of significant skin clearance with… PR Newswire (Press Release)21:38 18-Nov-24
Settlements Don’t Close the Door: Antitrust Claims Follow IPR Challenges in Life Sciences JD Supra19:40 18-Nov-24
Court closes case against Johnson&Johnson baby powder The Star, Kenya10:54 18-Nov-24
Microstrategy’s $26 Billion Bitcoin Stash Now Exceeds IBM and Nike Holdings Coinpedia09:33 17-Nov-24
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program Investopedia19:00 15-Nov-24
CHMP recommends RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of… GlobeNewswire (Press Release)15:17 15-Nov-24
Tremfya's Promising Debut Boosts Momentum for IL-23 Class in Ulcerative Colitis Treatment, According to Spherix Global… GlobeNewswire (Press Release)14:39 15-Nov-24
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Benzinga12:29 15-Nov-24
J&J’s nipocalimab shows promise in Phase II Sjögren’s disease trial Clinical Trials Arena11:56 15-Nov-24
Johnson & Johnson MedTech announces partnership for soft tissue solutions Verdict Medical Devices11:54 15-Nov-24

      
            
      
    view more headlines
   
      
      
      
12 Dec 22:58
   
About our Johnson & Johnson news

Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.
Johnson and Johnson

Latest News

About our Johnson & Johnson news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories
